ERBB2 and breast carcinoma: Breast cancer (BC) is a heterogeneous disease, which is subclassified into categories depending on the expression of estrogen and progesterone receptors and the amplification of human epidermal growth factor receptor 2 (HER2/ERBB2) [1].